Predictors of LexisNexis residential history availability and registry data concordance for childhood cancer research.
AI interpretation is pending for this paper.
Open original publication →What the AI sees
Not AI summarized yet.
Research significance
Pending deeper interpretation.
Source abstract
BACKGROUND: Use of a commercial database to obtain residential history information in environmental epidemiologic studies of cancer can lead to information bias if data availability varies by individual sociodemographic factors or case status. Residential data that are not missing at random and data that are discordant with cancer registry or birth record address data can impact subsequent exposure assessments. In our study of childhood cancers, we aimed to determine if the availability of residential history information differs by case status or other potential confounders and if there was agreement with cancer registry and birth records address data. METHODS: We worked with LexisNexis to retrieve residential histories for mothers of 3573 childhood cancer cases and 7160 controls born 2000-2015 in Los Angeles and Orange Counties in Southern California. We used linear regression to determine independent predictors of having residential history returned by LexisNexis. We assessed concordance between maternal address at birth and child's address at diagnosis available from registry data and the LexisNexis residential history by comparing street addresses and geocoded coordinates. RESULTS: Maternal characteristics (birthplace, race and ethnicity, education, insurance provider) and child's case status were associated with the mother having any address returned by LexisNexis. When comparing geocoded coordinates of cases, less than 10% of LexisNexis addresses during the diagnosis year matched cancer registry addresses. Birth record addresses matched LexisNexis-provided addresses for 47% of mothers. CONCLUSION(S): This study elucidates potential implications of using commercial databases such as LexisNexis to reconstruct residential histories and derive exposure measures in cancer case-control studies.